Signaling Pathway on the Effect of Oxygenated Warm Perfusion Prior to Cold Preservation of the Liver Grafts From Non-Heart-Beating Donors, and the Additive Effect of Edaravone

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 49-51

  Kobayashi, Y ^a   Akamatsu, Y ^a   Iwane, T ^a   Nakamura, A ^a   Satomi, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NORPHENAZONE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; CRYOPRESERVATION; EX VIVO STUDY; LIVER GRAFT; LIVER PERFUSION; MALE; NICK END LABELING; NON HEART BEATING DONOR; NONHUMAN; ORGAN DONOR; OXYGENATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ALANINE TRANSAMINASE; ANIMALS; ANTIPYRINE; BILE; FREE RADICAL SCAVENGERS; LIVER TRANSPLANTATION; MALE; MALONDIALDEHYDE; ORGAN PRESERVATION; RATS; RATS, WISTAR; REPERFUSION;

EID: 60649100882     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.09.055     Document Type: Article

References (14)

1. Otero A., Gómez-Gutiérrez M., Suárez F., et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation 76 (2003) 1068
2. Uarez F., Otero A., Solla M., et al. Biliary complications after liver transplantation from Maastricht category-2 non-heart-beating donors. Transplantation 85 (2008) 9
3. Iwane T., Akamatsu Y., Narita T., et al. The effect of perfusion prior to cold preservation and addition of biliverdin on the liver graft from non-heart-beating donors. Transplant Proc 38 (2006) 3358
4. Ott M., Gogvadze V., Orrenius S., et al. Mitochondria, oxidative stress and cell death. Apoptosis 12 (2007) 913
5. Kaizu T., Ikeda A., Nakao A., et al. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol 294 (2008) 236
6. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15
7. Reddy S., Zilvetti M., Brockmenn J., et al. Liver transplantation from non-heart-beating donors: current status and future prospects. Liver Transpl 10 (2004) 1223
8. Uehara T., Bennett B., Steve T., et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol 42 (2005) 850
9. Yamamoto K., Ichijo H., and Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19 (1999) 8469
10. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 39 (2007) 443
11. Ghatan S., Larne S., Kinoshita Y., et al. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150 (2000) 335
12. Ninomiya M., Shimada M., Harada N., et al. Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. Transplantation 74 (2002) 1470
13. Okatani Y., Wakatsuki A., and Enzan H. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver. Eur J Pharmacol 465 (2003) 163
14. Abe T., Unno M., Takeuchi H., et al. A new free radical scavenger, edaravone, ameliorates oxidative liver damage due to ischemia-reperfusion in vitro and in vivo. J Gastrointest Surg 8 (2004) 604